

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 6.38167416 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.23259980 |
| 3 | synaptic vesicle maturation (GO:0016188) | 6.12934495 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.93836881 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.79593209 |
| 6 | behavioral response to nicotine (GO:0035095) | 5.77143074 |
| 7 | vocalization behavior (GO:0071625) | 5.72916333 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.42140276 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.35671108 |
| 10 | neuronal action potential propagation (GO:0019227) | 5.22555295 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.18279863 |
| 12 | glutamate secretion (GO:0014047) | 5.04771625 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.91321573 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 4.88678864 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.86470105 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.68118231 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 4.66833446 |
| 18 | exploration behavior (GO:0035640) | 4.59785227 |
| 19 | cerebellar granule cell differentiation (GO:0021707) | 4.58782329 |
| 20 | * synaptic transmission, glutamatergic (GO:0035249) | 4.55493580 |
| 21 | * neurotransmitter secretion (GO:0007269) | 4.55183671 |
| 22 | sodium ion export (GO:0071436) | 4.44044931 |
| 23 | protein localization to synapse (GO:0035418) | 4.36167058 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 4.36156433 |
| 25 | long-term memory (GO:0007616) | 4.35781526 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 4.34306365 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.32520572 |
| 28 | serotonin metabolic process (GO:0042428) | 4.30170765 |
| 29 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.28765225 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.23794288 |
| 31 | layer formation in cerebral cortex (GO:0021819) | 4.23653616 |
| 32 | response to pheromone (GO:0019236) | 4.21110944 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.18111094 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 4.17313333 |
| 35 | * neuron-neuron synaptic transmission (GO:0007270) | 4.10192746 |
| 36 | dendritic spine morphogenesis (GO:0060997) | 4.04926248 |
| 37 | sulfation (GO:0051923) | 4.01498848 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.99768264 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.97827423 |
| 40 | * cerebellar Purkinje cell differentiation (GO:0021702) | 3.97814528 |
| 41 | primary amino compound metabolic process (GO:1901160) | 3.96159256 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.93271829 |
| 43 | regulation of synapse structural plasticity (GO:0051823) | 3.93102910 |
| 44 | neuromuscular process controlling posture (GO:0050884) | 3.88764471 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.86478668 |
| 46 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.84351323 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.78920786 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.77905079 |
| 49 | cellular response to ATP (GO:0071318) | 3.75863667 |
| 50 | proline transport (GO:0015824) | 3.74206589 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.73571462 |
| 52 | * gamma-aminobutyric acid transport (GO:0015812) | 3.70461613 |
| 53 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.67410735 |
| 54 | * neurotransmitter transport (GO:0006836) | 3.67093143 |
| 55 | * neuromuscular process controlling balance (GO:0050885) | 3.65105983 |
| 56 | cell communication by electrical coupling (GO:0010644) | 3.59740599 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.50397872 |
| 58 | glycine transport (GO:0015816) | 3.49962557 |
| 59 | regulation of synaptic plasticity (GO:0048167) | 3.45714496 |
| 60 | * membrane depolarization during action potential (GO:0086010) | 3.45286939 |
| 61 | * regulation of neurotransmitter levels (GO:0001505) | 3.39576946 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.38949791 |
| 63 | regulation of synapse maturation (GO:0090128) | 3.37874788 |
| 64 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.37239131 |
| 65 | auditory behavior (GO:0031223) | 3.36135385 |
| 66 | * membrane depolarization (GO:0051899) | 3.35878116 |
| 67 | * gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.35455742 |
| 68 | potassium ion import (GO:0010107) | 3.35395705 |
| 69 | presynaptic membrane assembly (GO:0097105) | 3.35183577 |
| 70 | * regulation of neurotransmitter secretion (GO:0046928) | 3.34749737 |
| 71 | regulation of ARF protein signal transduction (GO:0032012) | 3.33691533 |
| 72 | neuronal action potential (GO:0019228) | 3.32805911 |
| 73 | cell proliferation in forebrain (GO:0021846) | 3.32519694 |
| 74 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.31595796 |
| 75 | * cell differentiation in hindbrain (GO:0021533) | 3.31538620 |
| 76 | regulation of neurotransmitter uptake (GO:0051580) | 3.28832578 |
| 77 | chemosensory behavior (GO:0007635) | 3.28292893 |
| 78 | postsynaptic membrane organization (GO:0001941) | 3.28122397 |
| 79 | membrane hyperpolarization (GO:0060081) | 3.27669945 |
| 80 | presynaptic membrane organization (GO:0097090) | 3.26156742 |
| 81 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.25835214 |
| 82 | neuron recognition (GO:0008038) | 3.24537901 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.23388413 |
| 84 | regulation of vesicle fusion (GO:0031338) | 3.22043710 |
| 85 | prepulse inhibition (GO:0060134) | 3.21899472 |
| 86 | indole-containing compound metabolic process (GO:0042430) | 3.20987435 |
| 87 | axonal fasciculation (GO:0007413) | 3.17403412 |
| 88 | long-term synaptic potentiation (GO:0060291) | 3.16868633 |
| 89 | * transmission of nerve impulse (GO:0019226) | 3.16635765 |
| 90 | * dendrite morphogenesis (GO:0048813) | 3.15468489 |
| 91 | axon ensheathment in central nervous system (GO:0032291) | 3.13445592 |
| 92 | central nervous system myelination (GO:0022010) | 3.13445592 |
| 93 | L-amino acid import (GO:0043092) | 3.12351798 |
| 94 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.08874187 |
| 95 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.08813459 |
| 96 | response to auditory stimulus (GO:0010996) | 3.08118595 |
| 97 | cellular sodium ion homeostasis (GO:0006883) | 3.06841012 |
| 98 | kynurenine metabolic process (GO:0070189) | 3.06466360 |
| 99 | * regulation of neurotransmitter transport (GO:0051588) | 3.06288984 |
| 100 | positive regulation of dendritic spine development (GO:0060999) | 3.06122584 |
| 101 | * neuromuscular process (GO:0050905) | 3.04604284 |
| 102 | innervation (GO:0060384) | 3.04278491 |
| 103 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.03527112 |
| 104 | indolalkylamine metabolic process (GO:0006586) | 3.02608392 |
| 105 | indolalkylamine catabolic process (GO:0046218) | 3.02548450 |
| 106 | tryptophan catabolic process (GO:0006569) | 3.02548450 |
| 107 | indole-containing compound catabolic process (GO:0042436) | 3.02548450 |
| 108 | spinal cord development (GO:0021510) | 3.01016936 |
| 109 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.00120308 |
| 110 | neuronal ion channel clustering (GO:0045161) | 2.99949591 |
| 111 | social behavior (GO:0035176) | 2.98752459 |
| 112 | intraspecies interaction between organisms (GO:0051703) | 2.98752459 |
| 113 | learning (GO:0007612) | 2.98738097 |
| 114 | establishment of nucleus localization (GO:0040023) | 2.98723234 |
| 115 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.98447094 |
| 116 | * adult walking behavior (GO:0007628) | 2.98401006 |
| 117 | vesicle transport along microtubule (GO:0047496) | 2.97739697 |
| 118 | potassium ion homeostasis (GO:0055075) | 2.97276778 |
| 119 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.96554868 |
| 120 | dendritic spine organization (GO:0097061) | 2.96460080 |
| 121 | startle response (GO:0001964) | 2.89840880 |
| 122 | regulation of gene silencing by RNA (GO:0060966) | 2.88590442 |
| 123 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.88590442 |
| 124 | regulation of gene silencing by miRNA (GO:0060964) | 2.88590442 |
| 125 | nephron tubule morphogenesis (GO:0072078) | 2.87325442 |
| 126 | nephron epithelium morphogenesis (GO:0072088) | 2.87325442 |
| 127 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.83762266 |
| 128 | detection of light stimulus involved in visual perception (GO:0050908) | 2.83762266 |
| 129 | phosphorelay signal transduction system (GO:0000160) | 2.79695483 |
| 130 | cellular potassium ion transport (GO:0071804) | 2.79078033 |
| 131 | potassium ion transmembrane transport (GO:0071805) | 2.79078033 |
| 132 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.78029837 |
| 133 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.78029837 |
| 134 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.74638141 |
| 135 | mechanosensory behavior (GO:0007638) | 2.74404203 |
| 136 | protein polyglutamylation (GO:0018095) | 2.73873466 |
| 137 | peristalsis (GO:0030432) | 2.72572783 |
| 138 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.72197644 |
| 139 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.72197644 |
| 140 | limb development (GO:0060173) | 2.69800382 |
| 141 | appendage development (GO:0048736) | 2.69800382 |
| 142 | ovulation cycle (GO:0042698) | 2.67436241 |
| 143 | action potential (GO:0001508) | 2.66666085 |
| 144 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.66012045 |
| 145 | alanine transport (GO:0032328) | 2.64202697 |
| 146 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.64161922 |
| 147 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.61722233 |
| 148 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.59475812 |
| 149 | potassium ion transport (GO:0006813) | 2.58023992 |
| 150 | regulation of action potential (GO:0098900) | 2.57073210 |
| 151 | negative regulation of appetite (GO:0032099) | 2.56648564 |
| 152 | negative regulation of response to food (GO:0032096) | 2.56648564 |
| 153 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.56289863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.17004178 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24941224 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02404656 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99062454 |
| 5 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.97859071 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.92661184 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.85386052 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70497832 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70497832 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.57352616 |
| 11 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.56739108 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54220465 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49580118 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44865233 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43087747 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38933413 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35485765 |
| 18 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.34333061 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25833629 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25161610 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23903881 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.20033304 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.17862392 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16253631 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15617463 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12911247 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96637732 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.93619192 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86978172 |
| 30 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.81726035 |
| 31 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72255355 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.71507568 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70293184 |
| 34 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68403082 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61346978 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60133887 |
| 37 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.54606445 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52852421 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.48367093 |
| 40 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45650292 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45382818 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39264276 |
| 43 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37667477 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37425921 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36775376 |
| 46 | * AR_19668381_ChIP-Seq_PC3_Human | 1.32895784 |
| 47 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29867183 |
| 48 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.29189138 |
| 49 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28641483 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26279554 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25237421 |
| 52 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23785159 |
| 53 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23005748 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22972492 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21678261 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21582461 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19680425 |
| 58 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.18205670 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17602896 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16344571 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15412391 |
| 62 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15060857 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15036642 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14098646 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13641143 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13632590 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13626839 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13624149 |
| 69 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13060654 |
| 70 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11003418 |
| 71 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09580289 |
| 72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09200549 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08840809 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08583032 |
| 75 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08526293 |
| 76 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08103676 |
| 77 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07164075 |
| 78 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06783162 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06597479 |
| 80 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06476455 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06403440 |
| 82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06165544 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06165544 |
| 84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05995840 |
| 85 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05975453 |
| 86 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05952832 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04966869 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03931298 |
| 89 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03914350 |
| 90 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.03442176 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02781208 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02439800 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01506611 |
| 94 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00906427 |
| 95 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00829250 |
| 96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00763528 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00192600 |
| 98 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99605105 |
| 99 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99182741 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98934283 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97995593 |
| 102 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97540389 |
| 103 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96889043 |
| 104 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96867192 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96346818 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95978994 |
| 107 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95837595 |
| 108 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95572460 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94896517 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94395815 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94389086 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92945431 |
| 113 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92809076 |
| 114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92763662 |
| 115 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92722411 |
| 116 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92326060 |
| 117 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91881189 |
| 118 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91881189 |
| 119 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91613289 |
| 120 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88738799 |
| 121 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88355972 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87907279 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87128781 |
| 124 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86198585 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85172717 |
| 126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85084396 |
| 127 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84706836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.85020473 |
| 2 | * MP0003635_abnormal_synaptic_transmissio | 4.31957819 |
| 3 | MP0003880_abnormal_central_pattern | 4.13234387 |
| 4 | * MP0009046_muscle_twitch | 3.82380361 |
| 5 | MP0004270_analgesia | 3.67057115 |
| 6 | * MP0009745_abnormal_behavioral_response | 3.41197582 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.25660821 |
| 8 | * MP0002064_seizures | 3.23269506 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.02186657 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.93183244 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.86005770 |
| 12 | * MP0002272_abnormal_nervous_system | 2.79282148 |
| 13 | * MP0002734_abnormal_mechanical_nocicepti | 2.60960398 |
| 14 | MP0001486_abnormal_startle_reflex | 2.59093780 |
| 15 | MP0003646_muscle_fatigue | 2.54995857 |
| 16 | * MP0008569_lethality_at_weaning | 2.44215372 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.39972598 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.35664230 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.33792291 |
| 20 | MP0002736_abnormal_nociception_after | 2.29199641 |
| 21 | * MP0002067_abnormal_sensory_capabilities | 2.22875493 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.17640266 |
| 23 | MP0002184_abnormal_innervation | 2.04338356 |
| 24 | * MP0002733_abnormal_thermal_nociception | 1.93734269 |
| 25 | * MP0001970_abnormal_pain_threshold | 1.91423382 |
| 26 | MP0002822_catalepsy | 1.88308061 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.85879213 |
| 28 | MP0004858_abnormal_nervous_system | 1.84847968 |
| 29 | MP0006292_abnormal_olfactory_placode | 1.84798347 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.83939296 |
| 31 | * MP0002557_abnormal_social/conspecific_i | 1.77448167 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.75568433 |
| 33 | MP0003329_amyloid_beta_deposits | 1.74701060 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.73227819 |
| 35 | MP0004924_abnormal_behavior | 1.73227819 |
| 36 | MP0004130_abnormal_muscle_cell | 1.71142349 |
| 37 | MP0000778_abnormal_nervous_system | 1.69814683 |
| 38 | MP0003879_abnormal_hair_cell | 1.68246746 |
| 39 | MP0000955_abnormal_spinal_cord | 1.67905099 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.67642345 |
| 41 | MP0004885_abnormal_endolymph | 1.58080882 |
| 42 | MP0003787_abnormal_imprinting | 1.56021151 |
| 43 | MP0003195_calcinosis | 1.54597854 |
| 44 | MP0008877_abnormal_DNA_methylation | 1.53669067 |
| 45 | * MP0002066_abnormal_motor_capabilities/c | 1.51066067 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.50070101 |
| 47 | MP0004133_heterotaxia | 1.44805173 |
| 48 | MP0003283_abnormal_digestive_organ | 1.42630945 |
| 49 | * MP0002882_abnormal_neuron_morphology | 1.42330228 |
| 50 | * MP0003633_abnormal_nervous_system | 1.34532564 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.33725097 |
| 52 | MP0002160_abnormal_reproductive_system | 1.31067827 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.29236808 |
| 54 | MP0003878_abnormal_ear_physiology | 1.29236808 |
| 55 | MP0001984_abnormal_olfaction | 1.29014092 |
| 56 | MP0003136_yellow_coat_color | 1.25763090 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.25754407 |
| 58 | * MP0003631_nervous_system_phenotype | 1.22471097 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.19986884 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.19230796 |
| 61 | MP0003119_abnormal_digestive_system | 1.18111269 |
| 62 | * MP0002152_abnormal_brain_morphology | 1.17852616 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.17308026 |
| 64 | MP0004742_abnormal_vestibular_system | 1.15409533 |
| 65 | * MP0004142_abnormal_muscle_tone | 1.15112591 |
| 66 | MP0000026_abnormal_inner_ear | 1.13753072 |
| 67 | MP0002928_abnormal_bile_duct | 1.13579771 |
| 68 | MP0002249_abnormal_larynx_morphology | 1.13471064 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.11817913 |
| 70 | MP0004147_increased_porphyrin_level | 1.08172243 |
| 71 | MP0001188_hyperpigmentation | 1.07033307 |
| 72 | MP0002229_neurodegeneration | 1.04448176 |
| 73 | MP0008961_abnormal_basal_metabolism | 1.04228815 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.03037216 |
| 75 | * MP0003632_abnormal_nervous_system | 1.01269916 |
| 76 | MP0004134_abnormal_chest_morphology | 1.00738778 |
| 77 | MP0005253_abnormal_eye_physiology | 1.00663213 |
| 78 | MP0003122_maternal_imprinting | 0.99481551 |
| 79 | MP0003690_abnormal_glial_cell | 0.98504440 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 0.98074023 |
| 81 | MP0000049_abnormal_middle_ear | 0.97878867 |
| 82 | MP0005448_abnormal_energy_balance | 0.92940116 |
| 83 | MP0002069_abnormal_eating/drinking_beha | 0.92173375 |
| 84 | MP0003938_abnormal_ear_development | 0.90508208 |
| 85 | MP0004510_myositis | 0.89986825 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.89513320 |
| 87 | MP0003634_abnormal_glial_cell | 0.87920554 |
| 88 | MP0001348_abnormal_lacrimal_gland | 0.87821852 |
| 89 | MP0000920_abnormal_myelination | 0.87407283 |
| 90 | MP0008874_decreased_physiological_sensi | 0.87307492 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.86256953 |
| 92 | MP0005389_reproductive_system_phenotype | 0.83706837 |
| 93 | MP0000751_myopathy | 0.83174288 |
| 94 | MP0004085_abnormal_heartbeat | 0.83157847 |
| 95 | MP0005195_abnormal_posterior_eye | 0.82482529 |
| 96 | MP0001177_atelectasis | 0.81567058 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 0.80702316 |
| 98 | MP0003045_fibrosis | 0.80436820 |
| 99 | MP0010386_abnormal_urinary_bladder | 0.80146377 |
| 100 | MP0000604_amyloidosis | 0.79014969 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.78711847 |
| 102 | MP0004043_abnormal_pH_regulation | 0.77984110 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.77754074 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.77679289 |
| 105 | MP0001905_abnormal_dopamine_level | 0.77360432 |
| 106 | * MP0008872_abnormal_physiological_respon | 0.76438574 |
| 107 | * MP0004145_abnormal_muscle_electrophysio | 0.75902575 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.75852743 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.74911003 |
| 110 | MP0002938_white_spotting | 0.74470745 |
| 111 | MP0005535_abnormal_body_temperature | 0.74273255 |
| 112 | MP0002102_abnormal_ear_morphology | 0.74018686 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.71969566 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.71790539 |
| 115 | MP0005670_abnormal_white_adipose | 0.71790079 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.71493887 |
| 117 | MP0003075_altered_response_to | 0.70801540 |
| 118 | MP0002752_abnormal_somatic_nervous | 0.69449157 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.65821300 |
| 120 | * MP0010769_abnormal_survival | 0.65269389 |
| 121 | MP0004484_altered_response_of | 0.65007278 |
| 122 | MP0004233_abnormal_muscle_weight | 0.62849376 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.61785261 |
| 124 | * MP0010768_mortality/aging | 0.61784721 |
| 125 | * MP0002082_postnatal_lethality | 0.61413505 |
| 126 | * MP0010770_preweaning_lethality | 0.61413505 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.60766795 |
| 128 | MP0005394_taste/olfaction_phenotype | 0.58712955 |
| 129 | MP0005499_abnormal_olfactory_system | 0.58712955 |
| 130 | * MP0003861_abnormal_nervous_system | 0.57939901 |
| 131 | MP0001529_abnormal_vocalization | 0.56659885 |
| 132 | MP0003183_abnormal_peptide_metabolism | 0.55600250 |
| 133 | MP0002090_abnormal_vision | 0.54063512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.25186511 |
| 2 | Myokymia (HP:0002411) | 6.40750324 |
| 3 | Focal seizures (HP:0007359) | 6.04136770 |
| 4 | Action tremor (HP:0002345) | 5.70754738 |
| 5 | * Progressive cerebellar ataxia (HP:0002073) | 4.98548686 |
| 6 | Febrile seizures (HP:0002373) | 4.77366211 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.71256308 |
| 8 | Atonic seizures (HP:0010819) | 4.66226813 |
| 9 | * Visual hallucinations (HP:0002367) | 4.12574309 |
| 10 | Broad-based gait (HP:0002136) | 4.06577810 |
| 11 | Absence seizures (HP:0002121) | 4.05235974 |
| 12 | * Gaze-evoked nystagmus (HP:0000640) | 4.01270259 |
| 13 | Dysdiadochokinesis (HP:0002075) | 4.00316152 |
| 14 | Congenital stationary night blindness (HP:0007642) | 3.87931830 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.77495157 |
| 16 | Scanning speech (HP:0002168) | 3.70945268 |
| 17 | Dialeptic seizures (HP:0011146) | 3.68783936 |
| 18 | Dysmetria (HP:0001310) | 3.60847637 |
| 19 | Poor eye contact (HP:0000817) | 3.58937885 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.55035708 |
| 21 | Pancreatic cysts (HP:0001737) | 3.48458399 |
| 22 | Dysmetric saccades (HP:0000641) | 3.48392347 |
| 23 | Truncal ataxia (HP:0002078) | 3.40608857 |
| 24 | Pancreatic fibrosis (HP:0100732) | 3.39520875 |
| 25 | Impaired social interactions (HP:0000735) | 3.29680109 |
| 26 | Abnormal social behavior (HP:0012433) | 3.29680109 |
| 27 | Depression (HP:0000716) | 3.29086432 |
| 28 | True hermaphroditism (HP:0010459) | 3.27144072 |
| 29 | Nephronophthisis (HP:0000090) | 3.26944262 |
| 30 | Intention tremor (HP:0002080) | 3.26199743 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 3.25605646 |
| 32 | * Impaired smooth pursuit (HP:0007772) | 3.22898999 |
| 33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.15947566 |
| 34 | Ankle clonus (HP:0011448) | 3.13481897 |
| 35 | Postural instability (HP:0002172) | 3.12048237 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.10138617 |
| 37 | Molar tooth sign on MRI (HP:0002419) | 3.03645609 |
| 38 | Abnormality of midbrain morphology (HP:0002418) | 3.03645609 |
| 39 | Mutism (HP:0002300) | 3.01503542 |
| 40 | * Abnormality of ocular smooth pursuit (HP:0000617) | 3.00233123 |
| 41 | Cystic liver disease (HP:0006706) | 2.99734467 |
| 42 | Status epilepticus (HP:0002133) | 2.79895338 |
| 43 | Pendular nystagmus (HP:0012043) | 2.78511593 |
| 44 | Abnormality of the renal medulla (HP:0100957) | 2.71229220 |
| 45 | Excessive salivation (HP:0003781) | 2.71029442 |
| 46 | Drooling (HP:0002307) | 2.71029442 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.69383558 |
| 48 | Papilledema (HP:0001085) | 2.65135868 |
| 49 | Spastic gait (HP:0002064) | 2.63643058 |
| 50 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.58378495 |
| 51 | Annular pancreas (HP:0001734) | 2.56008286 |
| 52 | Decreased central vision (HP:0007663) | 2.54297406 |
| 53 | Ventricular fibrillation (HP:0001663) | 2.52896192 |
| 54 | Stereotypic behavior (HP:0000733) | 2.52542004 |
| 55 | Absent speech (HP:0001344) | 2.48906271 |
| 56 | Abnormality of the corticospinal tract (HP:0002492) | 2.48287040 |
| 57 | Clumsiness (HP:0002312) | 2.47629512 |
| 58 | * Anxiety (HP:0000739) | 2.47606833 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.47078193 |
| 60 | Amblyopia (HP:0000646) | 2.46706519 |
| 61 | Postural tremor (HP:0002174) | 2.46338814 |
| 62 | Chronic hepatic failure (HP:0100626) | 2.44097141 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.44069198 |
| 64 | Bradykinesia (HP:0002067) | 2.43977313 |
| 65 | Congenital sensorineural hearing impairment (HP:0008527) | 2.42165181 |
| 66 | Inability to walk (HP:0002540) | 2.42092600 |
| 67 | Abnormality of saccadic eye movements (HP:0000570) | 2.40597109 |
| 68 | Hyperventilation (HP:0002883) | 2.40304989 |
| 69 | Pointed chin (HP:0000307) | 2.38467336 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.36985574 |
| 71 | Tetraplegia (HP:0002445) | 2.35129665 |
| 72 | Urinary urgency (HP:0000012) | 2.34081039 |
| 73 | Neuronal loss in central nervous system (HP:0002529) | 2.32450022 |
| 74 | Furrowed tongue (HP:0000221) | 2.30485581 |
| 75 | Hypsarrhythmia (HP:0002521) | 2.27766133 |
| 76 | Gait ataxia (HP:0002066) | 2.27381426 |
| 77 | Progressive inability to walk (HP:0002505) | 2.26618972 |
| 78 | Sclerocornea (HP:0000647) | 2.26330851 |
| 79 | Abnormality of the nasal septum (HP:0000419) | 2.26170547 |
| 80 | Impaired vibratory sensation (HP:0002495) | 2.25262754 |
| 81 | Morphological abnormality of the middle ear (HP:0008609) | 2.23879623 |
| 82 | Type II lissencephaly (HP:0007260) | 2.22548586 |
| 83 | * Hemiplegia (HP:0002301) | 2.22346171 |
| 84 | Amyotrophic lateral sclerosis (HP:0007354) | 2.21896865 |
| 85 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.20213739 |
| 86 | Bundle branch block (HP:0011710) | 2.19306405 |
| 87 | * Hemiparesis (HP:0001269) | 2.16765505 |
| 88 | Limb ataxia (HP:0002070) | 2.15755540 |
| 89 | Methylmalonic acidemia (HP:0002912) | 2.14940772 |
| 90 | Hypoplastic ischia (HP:0003175) | 2.14401621 |
| 91 | Decreased circulating renin level (HP:0003351) | 2.13551154 |
| 92 | Keratoconus (HP:0000563) | 2.13478045 |
| 93 | Increased corneal curvature (HP:0100692) | 2.13478045 |
| 94 | Attenuation of retinal blood vessels (HP:0007843) | 2.12516318 |
| 95 | Abnormality of the renal cortex (HP:0011035) | 2.09196757 |
| 96 | Congenital, generalized hypertrichosis (HP:0004540) | 2.07051897 |
| 97 | Horizontal nystagmus (HP:0000666) | 2.06788209 |
| 98 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.05783387 |
| 99 | Obstructive sleep apnea (HP:0002870) | 2.04545570 |
| 100 | Abnormal drinking behavior (HP:0030082) | 2.04360681 |
| 101 | Polydipsia (HP:0001959) | 2.04360681 |
| 102 | Insomnia (HP:0100785) | 2.04139907 |
| 103 | Torticollis (HP:0000473) | 2.02440383 |
| 104 | Clonus (HP:0002169) | 2.01144371 |
| 105 | Tubular atrophy (HP:0000092) | 2.00901170 |
| 106 | Neurofibrillary tangles (HP:0002185) | 2.00576684 |
| 107 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97764048 |
| 108 | Methylmalonic aciduria (HP:0012120) | 1.97679398 |
| 109 | * Genetic anticipation (HP:0003743) | 1.97355898 |
| 110 | Lower limb asymmetry (HP:0100559) | 1.96846974 |
| 111 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96316360 |
| 112 | Focal dystonia (HP:0004373) | 1.96108358 |
| 113 | Patellar aplasia (HP:0006443) | 1.96028589 |
| 114 | Lower limb muscle weakness (HP:0007340) | 1.95594980 |
| 115 | Fetal akinesia sequence (HP:0001989) | 1.94795770 |
| 116 | Cerebral inclusion bodies (HP:0100314) | 1.94470300 |
| 117 | Severe visual impairment (HP:0001141) | 1.94099915 |
| 118 | Abnormality of the ischium (HP:0003174) | 1.92229121 |
| 119 | Megalencephaly (HP:0001355) | 1.92199607 |
| 120 | Optic nerve hypoplasia (HP:0000609) | 1.91950816 |
| 121 | Abnormality of the renal collecting system (HP:0004742) | 1.91496467 |
| 122 | Abnormality of the pubic bones (HP:0003172) | 1.91197600 |
| 123 | Aqueductal stenosis (HP:0002410) | 1.91194354 |
| 124 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.90593840 |
| 125 | Hamartoma of the eye (HP:0010568) | 1.89855724 |
| 126 | Inappropriate behavior (HP:0000719) | 1.89082083 |
| 127 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89045158 |
| 128 | Anencephaly (HP:0002323) | 1.88948269 |
| 129 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.87602992 |
| 130 | Short 1st metacarpal (HP:0010034) | 1.87602992 |
| 131 | Chorioretinal atrophy (HP:0000533) | 1.86392198 |
| 132 | Spinal canal stenosis (HP:0003416) | 1.85048428 |
| 133 | Short hallux (HP:0010109) | 1.83638917 |
| 134 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.82329579 |
| 135 | Truncal obesity (HP:0001956) | 1.81739007 |
| 136 | Abnormal EKG (HP:0003115) | 1.81725986 |
| 137 | Lower limb amyotrophy (HP:0007210) | 1.81045056 |
| 138 | Large for gestational age (HP:0001520) | 1.80465356 |
| 139 | Medial flaring of the eyebrow (HP:0010747) | 1.80047355 |
| 140 | Termporal pattern (HP:0011008) | 1.79691775 |
| 141 | Insidious onset (HP:0003587) | 1.79691775 |
| 142 | Rigidity (HP:0002063) | 1.79030882 |
| 143 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.78281353 |
| 144 | Neoplasm of the heart (HP:0100544) | 1.77714523 |
| 145 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.77479990 |
| 146 | Thyroid-stimulating hormone excess (HP:0002925) | 1.77209635 |
| 147 | Asplenia (HP:0001746) | 1.77074256 |
| 148 | Limb dystonia (HP:0002451) | 1.76235067 |
| 149 | Abnormality of salivation (HP:0100755) | 1.74785829 |
| 150 | Macroorchidism (HP:0000053) | 1.74383197 |
| 151 | Abnormality of the periventricular white matter (HP:0002518) | 1.74320870 |
| 152 | Cutaneous finger syndactyly (HP:0010554) | 1.73023069 |
| 153 | Oligodactyly (hands) (HP:0001180) | 1.72153580 |
| 154 | Goiter (HP:0000853) | 1.72065585 |
| 155 | Protruding tongue (HP:0010808) | 1.71932768 |
| 156 | Abnormality of alanine metabolism (HP:0010916) | 1.71398773 |
| 157 | Hyperalaninemia (HP:0003348) | 1.71398773 |
| 158 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.71398773 |
| 159 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.71334033 |
| 160 | Generalized myoclonic seizures (HP:0002123) | 1.70802037 |
| 161 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.70700308 |
| 162 | Pheochromocytoma (HP:0002666) | 1.70337060 |
| 163 | Male pseudohermaphroditism (HP:0000037) | 1.70122782 |
| 164 | * Diplopia (HP:0000651) | 1.68573365 |
| 165 | * Abnormality of binocular vision (HP:0011514) | 1.68573365 |
| 166 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.67653290 |
| 167 | * Incomplete penetrance (HP:0003829) | 1.65598479 |
| 168 | Slow progression (HP:0003677) | 1.65484439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.76380682 |
| 2 | NTRK3 | 4.85289789 |
| 3 | MAP3K9 | 3.84900941 |
| 4 | EPHA4 | 3.31800585 |
| 5 | MAP3K4 | 3.03177958 |
| 6 | GRK1 | 3.01958828 |
| 7 | MARK1 | 2.76321483 |
| 8 | DAPK2 | 2.67652013 |
| 9 | ADRBK2 | 2.56687393 |
| 10 | MINK1 | 2.52285132 |
| 11 | PAK6 | 2.42374543 |
| 12 | CAMKK1 | 2.35008732 |
| 13 | MAP2K7 | 2.32607874 |
| 14 | NTRK2 | 2.26341135 |
| 15 | CAMKK2 | 2.26293748 |
| 16 | BMPR1B | 2.23294513 |
| 17 | ACVR1B | 2.00985541 |
| 18 | STK38 | 1.98753675 |
| 19 | RIPK4 | 1.96233746 |
| 20 | PRKD3 | 1.90193611 |
| 21 | MAP2K4 | 1.87136609 |
| 22 | RIPK1 | 1.83953911 |
| 23 | NTRK1 | 1.76624862 |
| 24 | SIK2 | 1.73031168 |
| 25 | TLK1 | 1.65738845 |
| 26 | KSR2 | 1.55828928 |
| 27 | PNCK | 1.52947663 |
| 28 | TNIK | 1.52754486 |
| 29 | PRPF4B | 1.51752571 |
| 30 | CDK5 | 1.50470078 |
| 31 | WNK4 | 1.42900516 |
| 32 | DAPK1 | 1.41943288 |
| 33 | WNK1 | 1.39448147 |
| 34 | PRKCG | 1.31158328 |
| 35 | WNK3 | 1.30535389 |
| 36 | CDK19 | 1.28906539 |
| 37 | GRK5 | 1.27149986 |
| 38 | FES | 1.25369352 |
| 39 | MAPK13 | 1.22073497 |
| 40 | KSR1 | 1.21875056 |
| 41 | TYRO3 | 1.20570392 |
| 42 | UHMK1 | 1.16453796 |
| 43 | CAMK1 | 1.16250151 |
| 44 | MAP3K13 | 1.14665340 |
| 45 | CASK | 1.12014889 |
| 46 | CAMK1G | 1.09423884 |
| 47 | STK11 | 1.08154288 |
| 48 | ADRBK1 | 1.08049180 |
| 49 | FGFR2 | 1.07828219 |
| 50 | ALK | 1.07555763 |
| 51 | PLK2 | 1.06311373 |
| 52 | MAP3K2 | 1.05194544 |
| 53 | TAOK3 | 1.03369855 |
| 54 | PRKCH | 1.01488850 |
| 55 | MAP3K12 | 1.00031002 |
| 56 | SGK2 | 0.97486984 |
| 57 | TAOK1 | 0.96957916 |
| 58 | CDC42BPA | 0.95464885 |
| 59 | SGK494 | 0.95150446 |
| 60 | SGK223 | 0.95150446 |
| 61 | PHKG1 | 0.94309425 |
| 62 | PHKG2 | 0.94309425 |
| 63 | CAMK1D | 0.91564570 |
| 64 | MARK2 | 0.91155352 |
| 65 | SGK3 | 0.90285615 |
| 66 | ERBB2 | 0.89361175 |
| 67 | CAMK2A | 0.87437841 |
| 68 | CDK15 | 0.85755253 |
| 69 | SGK1 | 0.84966045 |
| 70 | ZAK | 0.84785189 |
| 71 | RET | 0.84553999 |
| 72 | CDK18 | 0.83922774 |
| 73 | MAP4K2 | 0.83741752 |
| 74 | PINK1 | 0.79829725 |
| 75 | CAMK2B | 0.79185154 |
| 76 | PKN1 | 0.75897384 |
| 77 | DYRK2 | 0.75348887 |
| 78 | CDK11A | 0.75043162 |
| 79 | CAMK4 | 0.74892413 |
| 80 | DYRK1A | 0.73772369 |
| 81 | STK39 | 0.73284125 |
| 82 | CDK14 | 0.72292220 |
| 83 | MAPK15 | 0.71698457 |
| 84 | NEK2 | 0.68104325 |
| 85 | PDK1 | 0.67278716 |
| 86 | NUAK1 | 0.66319023 |
| 87 | NEK6 | 0.65962443 |
| 88 | LATS2 | 0.65041971 |
| 89 | RPS6KA3 | 0.62428701 |
| 90 | PDPK1 | 0.60531281 |
| 91 | LMTK2 | 0.59710329 |
| 92 | MKNK2 | 0.59592053 |
| 93 | CSNK1G2 | 0.58393727 |
| 94 | MAP3K6 | 0.56854220 |
| 95 | CAMK2D | 0.56817701 |
| 96 | SCYL2 | 0.56391933 |
| 97 | TNK2 | 0.56170345 |
| 98 | MAPK10 | 0.55687277 |
| 99 | RPS6KA6 | 0.54462516 |
| 100 | PRKAA1 | 0.54038642 |
| 101 | PAK3 | 0.53874867 |
| 102 | CAMK2G | 0.53612222 |
| 103 | STK38L | 0.53576048 |
| 104 | OXSR1 | 0.52759746 |
| 105 | FYN | 0.52290808 |
| 106 | CSNK1A1 | 0.51772514 |
| 107 | BMPR2 | 0.51544609 |
| 108 | PRKACA | 0.50446375 |
| 109 | ICK | 0.48796634 |
| 110 | PTK2B | 0.47824368 |
| 111 | MAP3K7 | 0.46871492 |
| 112 | AKT3 | 0.46810631 |
| 113 | MAP2K6 | 0.46509752 |
| 114 | PRKCA | 0.44127173 |
| 115 | PTK2 | 0.44032117 |
| 116 | PRKCZ | 0.43809282 |
| 117 | ARAF | 0.43416725 |
| 118 | MAP3K1 | 0.43163534 |
| 119 | INSRR | 0.42013977 |
| 120 | PRKCE | 0.41750164 |
| 121 | TIE1 | 0.40643738 |
| 122 | HIPK2 | 0.40266375 |
| 123 | PRKG1 | 0.39934861 |
| 124 | RAF1 | 0.39335262 |
| 125 | PIK3CA | 0.38810182 |
| 126 | MAPKAPK5 | 0.38115542 |
| 127 | CSNK1D | 0.36419583 |
| 128 | MAP2K1 | 0.36369592 |
| 129 | CDC7 | 0.35627188 |
| 130 | PRKCB | 0.34862519 |
| 131 | TGFBR1 | 0.34765543 |
| 132 | GRK7 | 0.34115945 |
| 133 | PRKD2 | 0.33523956 |
| 134 | MAPK8 | 0.33391405 |
| 135 | CSNK1E | 0.33102922 |
| 136 | GSK3B | 0.33004725 |
| 137 | PRKDC | 0.31826924 |
| 138 | MUSK | 0.30605518 |
| 139 | MAPKAPK3 | 0.27302735 |
| 140 | CHUK | 0.26352667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nicotine addiction_Homo sapiens_hsa05033 | 3.73817506 |
| 2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94838783 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.85187160 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79463177 |
| 5 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.78933731 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.64952613 |
| 7 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.54813838 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.41583101 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.38533791 |
| 10 | * Morphine addiction_Homo sapiens_hsa05032 | 2.35307973 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.30722702 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.29595198 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.18623767 |
| 14 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.02046186 |
| 15 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 1.98703839 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.97605095 |
| 17 | * Long-term depression_Homo sapiens_hsa04730 | 1.89626609 |
| 18 | * Taste transduction_Homo sapiens_hsa04742 | 1.87943283 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.83084125 |
| 20 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.81174602 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71804415 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65422116 |
| 23 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58254740 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55369169 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53884010 |
| 26 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.51979009 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51525544 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.50640412 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.50429458 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49086424 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48963395 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.45084659 |
| 33 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.41731625 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.39149967 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.37507389 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32866794 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30919820 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.30723901 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.30560866 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29099734 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24882186 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19435456 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18349840 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17636291 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11228411 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10546670 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06217557 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.04497819 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01391466 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00516368 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99393243 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.98715944 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98707582 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96432734 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.95794133 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94929292 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.93712456 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93052438 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 0.92238863 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91502693 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91124462 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87449479 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82880432 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82722285 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81421229 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81253946 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80625590 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80603868 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79787973 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77981406 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77481236 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77456750 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77195241 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72328118 |
| 75 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71911008 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71117620 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69986167 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69376167 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68041179 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67154542 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.66962128 |
| 82 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.65976461 |
| 83 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.65143074 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.63172066 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62356305 |
| 86 | Melanoma_Homo sapiens_hsa05218 | 0.60893530 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60039205 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59339672 |
| 89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.58903247 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58614831 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57609806 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57582849 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56726911 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55105325 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54626059 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53252623 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53067705 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51536656 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51154492 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50838995 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50171764 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49686724 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48917991 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47644101 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47521829 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47378539 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.45496093 |
| 108 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45196634 |
| 109 | Phototransduction_Homo sapiens_hsa04744 | 0.44436886 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.42401670 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42297184 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42152534 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42102489 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42050490 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41265545 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40734126 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40502234 |
| 118 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38791323 |
| 119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38730412 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38681373 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38444181 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38231963 |
| 123 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37970432 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37424245 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37068163 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36557166 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34566164 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.33755319 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32770053 |
| 130 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31625335 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30699529 |
| 132 | Platelet activation_Homo sapiens_hsa04611 | 0.30233375 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29955622 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29827542 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.28683983 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27773370 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27720481 |
| 138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24661475 |

